Xylitol inhibits in vitro and in vivo angiogenesis by suppressing the NF-κB and Akt signaling pathways

Yi,Eui-Yeun; Kim,Yung-Jin

doi:10.3892/ijo.2013.1917

Xylitol inhibits in vitro and in vivo angiogenesis by suppressing the NF-κB and Akt signaling pathways

Authors:
- Eui-Yeun Yi
- Yung-Jin Kim
View Affiliations

Affiliations: Department of Molecular Biology, College of Natural Science, Pusan National University, Busan 609-735, Republic of Korea
Published online on: April 24, 2013 https://doi.org/10.3892/ijo.2013.1917
Pages: 315-320

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Angiogenesis is an important process involved in tumor growth and metastasis. Many studies have investigated the use of natural compounds such as angiogenic inhibitors. Xylitol is a 5-carbon sugar alcohol and is an artificial sweetener that has been used in chewing gums to prevent tooth decay. Xylitol has been also known to inhibit inflammatory cytokine expression induced by lipopolysaccharide (LPS). Since angiogenesis and inflammation share a common signaling pathway, we investigated the role of xylitol in angiogenesis. Xylitol inhibited the migration, invasion and tube formation of human umbilical vein endothelial cells (HUVECs). Xylitol also inhibited in vivo angiogenesis in a mouse Matrigel plug assay. Furthermore, mRNA expression of vascular endothelial growth factor (VEGF), VEGFR-II (KDR), basic fibroblast growth factor (bFGF), bFGFR‑II, matrix metalloproteinase-2 (MMP-2) and MMP-9 of HUVECs decreased following treatment with xylitol. These anti-angiogenic effects of xylitol are exerted through inhibition of NF-κB and Akt activation. Taken together, these results suggest that xylitol acts as a beneficial angiogenesis inhibitor.

View Figures

View References

1.	Folkman J and Shing Y: Angiogenesis. J Biol Chem. 267:10931–10934. 1992.
2.	Siddiqui FA, Desai H, Siddiqui TF and Francis JL: Hemoglobin induces the expression and secretion of vascular endothelial growth factor from human malignant cells. Hematol J. 3:264–270. 2002. View Article : Google Scholar : PubMed/NCBI
3.	Carmeliet P and Jain RK: Angiogenesis in cancer and other diseases. Nature. 407:249–257. 2000. View Article : Google Scholar : PubMed/NCBI
4.	Ferrara N and Kerbel RS: Angiogenesis as therapeutic target. Nature. 438:967–974. 2005. View Article : Google Scholar
5.	Isner JM and Asahara T: Angiogenesis and vasculogenesis as therapeutics strategies for postnatal neovascularization. J Clin Invest. 103:1231–1236. 1999. View Article : Google Scholar : PubMed/NCBI
6.	Folkman J: Tumor angiogenesis; therapeutic implications. N Engl J Med. 285:1182–1186. 1971. View Article : Google Scholar : PubMed/NCBI
7.	Szekanecz Z and Koch AE: Endothelial cells in inflammation and angiogenesis. Curr Drug Targets Inflam Allergy. 4:319–323. 2005. View Article : Google Scholar : PubMed/NCBI
8.	Ono M: Molecular links between tumor angiogenesis and inflammation: inflammatory stimuli of macrophages and cancer cells as targets for therapeutic strategy. Cancer Sci. 99:1501–1506. 2008. View Article : Google Scholar : PubMed/NCBI
9.	Karin M and Greteo FR: NF-κB: Linking inflammation and immunity to cancer development and progression. Nat Rev Immunol. 5:749–759. 2005.
10.	Albini A, Tosetti F, Benelli R and Noonan DM: Tumor inflammatory angiogenesis and its chemoprevention. Cancer Res. 65:10639–10641. 2005. View Article : Google Scholar
11.	Tanzer JM: Xylitol chewing gum and dental caries. Int Dent J. 45:65–76. 1995.PubMed/NCBI
12.	Bradshaw DJ and Marsh PD: Effect of sugar alcohols on the composition and metabolism of a mixed culture of oral bacteria grown in a chemostat. Caries Res. 28:251–256. 1994. View Article : Google Scholar : PubMed/NCBI
13.	Makinen KK and Soderling E: A quantitative study of mannitol, sorbitol, xylitol, and xylose in wild berries and commercial fruits. J Food Sci. 45:367–371. 1980. View Article : Google Scholar
14.	Makinen KK, Bennett CA, Hujoel PP, et al: Xylitol chewing gums and caries rates: a 40-month cohort study. J Dent Res. 74:1904–1913. 1995. View Article : Google Scholar : PubMed/NCBI
15.	Söderling E, Mäkinen KK, Chen CY, et al: Effect of sorbitol, xylitol, and xylitol/sorbitol chewing gums on dental plaque. Caries Res. 23:378–384. 1989.PubMed/NCBI
16.	Han SJ, Jeong SY, Nam YJ, et al: Xylitol inhibits inflammatory cytokine expression induced by lipopolysaccharide from Porphyromonas gingivalis. Clin Diagn Lab Immunol. 12:1285–1291. 2005.PubMed/NCBI
17.	Bisacchi D, Benelli R, Venzetto C, et al: Anti-angiognesis and angioprevention: mechanisms, problems and perspectives. Cancer Detect Prev. 27:229–238. 2003. View Article : Google Scholar : PubMed/NCBI
18.	Yoshimura A: Signal transduction of inflammatory cytokines and tumor development. Cancer Sci. 97:439–447. 2006. View Article : Google Scholar : PubMed/NCBI
19.	Pang R and Poon RT: Angiogenesis and antiangiogenic therapy in hepatocellular carcinoma. Cancer Lett. 242:151–167. 2006. View Article : Google Scholar : PubMed/NCBI
20.	Femke H and Arjan WG: Tumor vascularization: sprouting angiogenesis and beyond. Cancer Metastasis Rev. 26:489–502. 2007. View Article : Google Scholar
21.	Bergers G, Brekken R, McMahon G, et al: Matrix matalloproteinases-9 triggers the angiogenic switch during angiogenesis. Nature Cell Biol. 2:737–744. 2000. View Article : Google Scholar : PubMed/NCBI
22.	Francesco P and Antonio L: NF-κB solid tumors. Biochem Pharmacol. 1142–1152. 2006.
23.	Lin YG, Kunnumarkkara AB, Nair A, et al: Curcumin inhibits growth and angiogenesis in ovarian carcinoma by targeting the nuclear factor-κB pathway. Clin Cancer Res. 13:3423–3430. 2007.PubMed/NCBI
24.	Karin M: Nuclear factor-κB in cancer development and progression. Nature. 441:431–436. 2006.
25.	Pawel D, Kathryn H, Susan JB and Hong C: Antiangiogenic and antitumor efficacy of EphA2 receptor antagonist. Cancer Res. 64:910–919. 2004. View Article : Google Scholar : PubMed/NCBI
26.	Sporn MB and Suh N: Chemoprevention of cancer. Carcinogenesis. 21:525–530. 2000. View Article : Google Scholar : PubMed/NCBI
27.	Jones KM, Wang H, Peskar BM, et al: Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: insight into mechanism and implications for cancer growth ulcer healing. Nat Med. 5:1418–1423. 1999. View Article : Google Scholar : PubMed/NCBI
28.	Renko M, Valkonen P, Tapiainen T, et al: Xylitol-supplemented nutrition enhances bacterial killing and prolongs survival of rats in experimental pneumococcal sepsis. BMC Microbiol. 8:1–7. 2008. View Article : Google Scholar
29.	Georgieff M, Moldawer LL, Bistrian BR, et al: Xylitol, an energy source for intravenous nutrition after trauma. J Parenter Enteral Nutr. 9:199–209. 1985.PubMed/NCBI
30.	Panagiotou G, Christakopoulos P, Grotkjaer T, et al: Engineering of the redox imbalance of Fusarium oxysporum enables anaerobic growth on xylose. Metab Eng. 8:474–482. 2006.PubMed/NCBI
31.	Loesche WJ, Grossman NS, Earnest R, et al: The effect of chewing xylitol gum on the plaque and saliva levels of Streptococcus mutans. J Am Dent Assoc. 108:587–592. 1984. View Article : Google Scholar : PubMed/NCBI
32.	Miyasawa H, Iwami Y, Mayanagi H, et al: Xylitol inhibition of anaerobic acid production by Streptococcus mutans at various pH levels. Oral Microbiol Immunol. 18:215–219. 2003. View Article : Google Scholar : PubMed/NCBI
33.	Meadows KN, Bryant P and Pumiglia K: Vascular endothelial growth factor induction of the angiogenic phenotype requires ras activation. J Bio Chem. 276:49289–49298. 2001. View Article : Google Scholar : PubMed/NCBI
34.	Leung DW, Cachianes G, Kuang WJ, et al: Vascular endothelial growth factor is a secreted angiogenic mitogen. Science. 246:1306–1309. 1989. View Article : Google Scholar : PubMed/NCBI
35.	Asahara T, Bauters C, Zheng LP, et al: Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo. Circulation. 92:11365–11371. 1995. View Article : Google Scholar : PubMed/NCBI
36.	Gilmore TD: The Rel/NF-κB/IκB signal transduction pathway and cancer. Cancer Treat Res. 115:241–265. 2003.